Invited commentary: Are specific inherited mutations important in clinical management of hereditary cancer syndromes?

Surgery

Volumn 131, Issue 4, 2002, Pages 382-383

  Moley, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SUSCEPTIBILITY; CENTRAL NERVOUS SYSTEM TUMOR; CODON; DISEASE SEVERITY; FAMILIAL CANCER; FAMILIAL POLYPOSIS; FOLLOW UP; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HIRSCHSPRUNG DISEASE; HUMAN; HYPERPARATHYROIDISM; INHERITANCE; MULTIPLE ENDOCRINE NEOPLASIA; NOTE; PHEOCHROMOCYTOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINA PIGMENT DEGENERATION; RETINOBLASTOMA; SIPPLE SYNDROME; SYNDROME DELINEATION; THYROID MEDULLARY CARCINOMA; TUMOR SUPPRESSOR GENE; TURCOT SYNDROME; VON HIPPEL LINDAU DISEASE;

EID: 0036219072     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.121094     Document Type: Article

References (6)

1. Genetic testing for cancer predisposition
2. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: Report of the International RET mutation consortium
3. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A
4. Hereditary endocrinopathies
5. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease
6. Genetic identification of Mom-l, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse